Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.
Market Analysis and Insights: Global Artificial Intelligence in Diabetes Management Market
The global Artificial Intelligence in Diabetes Management market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Artificial Intelligence in Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Artificial Intelligence in Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Artificial Intelligence in Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Artificial Intelligence in Diabetes Management include Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Artificial Intelligence in Diabetes Management market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Intelligence in Diabetes Management, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Diabetes Management, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence in Diabetes Management revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence in Diabetes Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence in Diabetes Management revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc.
By Company
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone
Segment by Type
Case-based Reasoning
Intelligent Data Analysis
Segment by Application
Glucose Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence in Diabetes Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Diabetes Management companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Diabetes Management revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Diabetes Management Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Case-based Reasoning
1.2.3 Intelligent Data Analysis
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Diabetes Management Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Glucose Monitoring Devices
1.3.3 Diagnostic Devices
1.3.4 Insulin Delivery Devices
1.3.5 Other Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Diabetes Management Market Perspective (2018-2029)
2.2 Global Artificial Intelligence in Diabetes Management Growth Trends by Region
2.2.1 Artificial Intelligence in Diabetes Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence in Diabetes Management Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence in Diabetes Management Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence in Diabetes Management Market Dynamics
2.3.1 Artificial Intelligence in Diabetes Management Industry Trends
2.3.2 Artificial Intelligence in Diabetes Management Market Drivers
2.3.3 Artificial Intelligence in Diabetes Management Market Challenges
2.3.4 Artificial Intelligence in Diabetes Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Intelligence in Diabetes Management by Players
3.1.1 Global Artificial Intelligence in Diabetes Management Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence in Diabetes Management Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence in Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence in Diabetes Management, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Artificial Intelligence in Diabetes Management Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Diabetes Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Diabetes Management Revenue in 2022
3.5 Global Key Players of Artificial Intelligence in Diabetes Management Head office and Area Served
3.6 Global Key Players of Artificial Intelligence in Diabetes Management, Product and Application
3.7 Global Key Players of Artificial Intelligence in Diabetes Management, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Diabetes Management Breakdown Data by Type
4.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence in Diabetes Management Breakdown Data by Application
5.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
6.2 North America Artificial Intelligence in Diabetes Management Market Size by Type
6.2.1 North America Artificial Intelligence in Diabetes Management Market Size by Type (2018-2023)
6.2.2 North America Artificial Intelligence in Diabetes Management Market Size by Type (2024-2029)
6.2.3 North America Artificial Intelligence in Diabetes Management Market Share by Type (2018-2029)
6.3 North America Artificial Intelligence in Diabetes Management Market Size by Application
6.3.1 North America Artificial Intelligence in Diabetes Management Market Size by Application (2018-2023)
6.3.2 North America Artificial Intelligence in Diabetes Management Market Size by Application (2024-2029)
6.3.3 North America Artificial Intelligence in Diabetes Management Market Share by Application (2018-2029)
6.4 North America Artificial Intelligence in Diabetes Management Market Size by Country
6.4.1 North America Artificial Intelligence in Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
6.4.3 North America Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Artificial Intelligence in Diabetes Management Market Size (2018-2029)
7.2 Europe Artificial Intelligence in Diabetes Management Market Size by Type
7.2.1 Europe Artificial Intelligence in Diabetes Management Market Size by Type (2018-2023)
7.2.2 Europe Artificial Intelligence in Diabetes Management Market Size by Type (2024-2029)
7.2.3 Europe Artificial Intelligence in Diabetes Management Market Share by Type (2018-2029)
7.3 Europe Artificial Intelligence in Diabetes Management Market Size by Application
7.3.1 Europe Artificial Intelligence in Diabetes Management Market Size by Application (2018-2023)
7.3.2 Europe Artificial Intelligence in Diabetes Management Market Size by Application (2024-2029)
7.3.3 Europe Artificial Intelligence in Diabetes Management Market Share by Application (2018-2029)
7.4 Europe Artificial Intelligence in Diabetes Management Market Size by Country
7.4.1 Europe Artificial Intelligence in Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
7.4.3 Europe Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Intelligence in Diabetes Management Market Size (2018-2029)
8.2 China Artificial Intelligence in Diabetes Management Market Size by Type
8.2.1 China Artificial Intelligence in Diabetes Management Market Size by Type (2018-2023)
8.2.2 China Artificial Intelligence in Diabetes Management Market Size by Type (2024-2029)
8.2.3 China Artificial Intelligence in Diabetes Management Market Share by Type (2018-2029)
8.3 China Artificial Intelligence in Diabetes Management Market Size by Application
8.3.1 China Artificial Intelligence in Diabetes Management Market Size by Application (2018-2023)
8.3.2 China Artificial Intelligence in Diabetes Management Market Size by Application (2024-2029)
8.3.3 China Artificial Intelligence in Diabetes Management Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artificial Intelligence in Diabetes Management Market Size (2018-2029)
9.2 Asia Artificial Intelligence in Diabetes Management Market Size by Type
9.2.1 Asia Artificial Intelligence in Diabetes Management Market Size by Type (2018-2023)
9.2.2 Asia Artificial Intelligence in Diabetes Management Market Size by Type (2024-2029)
9.2.3 Asia Artificial Intelligence in Diabetes Management Market Share by Type (2018-2029)
9.3 Asia Artificial Intelligence in Diabetes Management Market Size by Application
9.3.1 Asia Artificial Intelligence in Diabetes Management Market Size by Application (2018-2023)
9.3.2 Asia Artificial Intelligence in Diabetes Management Market Size by Application (2024-2029)
9.3.3 Asia Artificial Intelligence in Diabetes Management Market Share by Application (2018-2029)
9.4 Asia Artificial Intelligence in Diabetes Management Market Size by Region
9.4.1 Asia Artificial Intelligence in Diabetes Management Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Intelligence in Diabetes Management Market Size by Region (2018-2023)
9.4.3 Asia Artificial Intelligence in Diabetes Management Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Apple
11.1.1 Apple Company Details
11.1.2 Apple Business Overview
11.1.3 Apple Artificial Intelligence in Diabetes Management Introduction
11.1.4 Apple Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.1.5 Apple Recent Developments
11.2 Diabnext
11.2.1 Diabnext Company Details
11.2.2 Diabnext Business Overview
11.2.3 Diabnext Artificial Intelligence in Diabetes Management Introduction
11.2.4 Diabnext Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.2.5 Diabnext Recent Developments
11.3 Glooko
11.3.1 Glooko Company Details
11.3.2 Glooko Business Overview
11.3.3 Glooko Artificial Intelligence in Diabetes Management Introduction
11.3.4 Glooko Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.3.5 Glooko Recent Developments
11.4 Google
11.4.1 Google Company Details
11.4.2 Google Business Overview
11.4.3 Google Artificial Intelligence in Diabetes Management Introduction
11.4.4 Google Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.4.5 Google Recent Developments
11.5 IBM
11.5.1 IBM Company Details
11.5.2 IBM Business Overview
11.5.3 IBM Artificial Intelligence in Diabetes Management Introduction
11.5.4 IBM Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.5.5 IBM Recent Developments
11.6 Tidepool
11.6.1 Tidepool Company Details
11.6.2 Tidepool Business Overview
11.6.3 Tidepool Artificial Intelligence in Diabetes Management Introduction
11.6.4 Tidepool Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.6.5 Tidepool Recent Developments
11.7 Vodafone
11.7.1 Vodafone Company Details
11.7.2 Vodafone Business Overview
11.7.3 Vodafone Artificial Intelligence in Diabetes Management Introduction
11.7.4 Vodafone Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.7.5 Vodafone Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone
*If Applicable.